×
About 2,148 results

ALLMedicine™ Haptoglobin Center

Research & Reviews  761 results

Identification of Cleaved Haptoglobin in the Serum of Bee Venom-Hypersensitive Patients.
https://doi.org/10.51507/j.jams.2021.14.3.102
Journal of Acupuncture and Meridian Studies; Ryu JM, Na HH et. al.

Jul 1st, 2022 - Bee venom has been used as a therapeutic compound for various human diseases in oriental medicine; however, it can induce anaphylaxis in hypersensitive patients during treatment. Anaphylaxis is an acute allergic reaction that occurs after allergen...

Plasma E-selectin and kallistatin as predictive markers of histologic chorioamnionitis ...
https://doi.org/10.1111/aji.13584
American Journal of Reproductive Immunology (New York, N.... Cho I, Lee KN et. al.

Jul 1st, 2022 - We aimed to assess the predictive potential of 12 plasma biomarkers to predict acute histologic chorioamnionitis (HCA) in women with preterm premature rupture of membranes (PPROM) and to develop multi-biomarker panels based on these biomarkers in ...

Cardiopulmonary Bypass Induced Red Blood Cell Lysis
https://clinicaltrials.gov/ct2/show/NCT05189262

Jun 30th, 2022 - Cost estimates for brain, lung, cardiac, and kidney complications following complex cardiac surgeries that require a medical assist device to by-pass the heart and lungs (cardiopulmonary bypass, CPB) is estimated to cost $80 million per individual...

Receipt of at least 4 units of low titer group O whole blood with titer <100 does not l...
https://doi.org/10.1111/trf.16980
Transfusion Yazer MH, Corcos A et. al.

Jun 25th, 2022 - The serological safety of transfusing low titer group O whole blood (LTOWB) with an anti-A and anti-B titer of <100 was evaluated in group O and non-group O trauma recipients. Civilian adult trauma patients who received ≥4 units of leukoreduced LT...

Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation
https://clinicaltrials.gov/ct2/show/NCT04908657

Jun 8th, 2022 - Research Design and Methods Patients and Methods Study cohort: The adolescent and adult patients (age ≥ 12 years) with anatomic and/or functional univentricular heart receive Fontan procedure and are followed at our institute will be included in o...

see more →

Clinicaltrials.gov  62 results

Cardiopulmonary Bypass Induced Red Blood Cell Lysis
https://clinicaltrials.gov/ct2/show/NCT05189262

Jun 30th, 2022 - Cost estimates for brain, lung, cardiac, and kidney complications following complex cardiac surgeries that require a medical assist device to by-pass the heart and lungs (cardiopulmonary bypass, CPB) is estimated to cost $80 million per individual...

Sildenafil for Liver Fibrosis in Adolescents and Adults After Fontan Operation
https://clinicaltrials.gov/ct2/show/NCT04908657

Jun 8th, 2022 - Research Design and Methods Patients and Methods Study cohort: The adolescent and adult patients (age ≥ 12 years) with anatomic and/or functional univentricular heart receive Fontan procedure and are followed at our institute will be included in o...

Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
https://clinicaltrials.gov/ct2/show/NCT03255928

May 5th, 2022 - The study is aimed at evaluating the patients' haemostatic and coagulation profile focusing, in particular, on platelet function. Platelet function will be analyzed utilizing two innovative analytic diagnostic tests, namely i) the Platelet Activit...

Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg
https://clinicaltrials.gov/ct2/show/NCT03762915

May 2nd, 2022 - A randomized controlled clinical trial of a control (SRP) group and an experimental (SRP with minocycline HCl microspheres, 1 mg) group is planned. The intervention of minocycline HCl microspheres, 1 mg will be administered in the experimental gro...

Safety and Efficacy of Different Regimens of Primaquine on Vivax Malaria Treatment in G6PD Deficient Patients
https://clinicaltrials.gov/ct2/show/NCT03529396

Mar 21st, 2022 - This is an open-label, randomized, phase II, clinical trial of safety and efficacy. Patients will be screened for eligibility and treated at the Fundação de Medicina Tropical Dr Heitor Vieira Dourado in Manaus and the Centro de Pesquisa em Medicin...

see more →

News  36 results

43-year-old male • fatigue • unintentional weight loss • pancytopenia • Dx?
https://www.mdedge.com/familymedicine/article/254462/musculoskeletal-disorders
MDedge Family Medicine; Isabella Buzzo Bellon Brout, MD, Caitlin A. Nicholson, MD et. al.

May 10th, 2022 - THE CASE A 43-year-old Black male presented to his primary care physician with an 8-month history of progressive fatigue, weakness, and unintentional weight loss. The patient’s history also included antiphospholipid antibody syndrome (APS) with pr.

Evans’ Syndrome in Undiagnosed Small Lymphocytic Lymphoma: Case Report and Literature Review
https://www.mdedge.com/fedprac/avaho/article/245949/lymphoma-plasma-cell-disorders/evans-syndrome-undiagnosed-small
Faith Opeyemi Abodunrin (faithabodunrin@creighton.edu), Abubakar Tauseef

Sep 10th, 2021 - Background Evans’ syndrome is a rare entity characterized by concomitant or sequential multilineage cytopenia particularly autoimmune hemolytic anemia, ITP and very rarely autoimmune neutropenia. Although more common in young adults, it can occur.

Transplant-Associated Thrombotic Microangiopathy: New Insights, Emerging Treatments
https://www.onclive.com/view/transplant-associated-thrombotic-microangiopathy-new-insights-emerging-treatments

Jul 22nd, 2021 - Transplant-associated thrombotic microangiopathy (TA-TMA) is a complication of stem cell transplants that can occur with peripherally mobilized stem cells or bone marrow-derived stem cells. TA-TMA remains a difficult complication to address, with ...

Challenges of Accurate Diagnosis of TA-TMA After Hematopoietic Stem Cell Transplant
https://www.onclive.com/view/challenges-of-accurate-diagnosis-of-ta-tma-after-hematopoietic-stem-cell-transplant

Apr 8th, 2021 - Samer Khaled, MD: That is a good segue to our next segment about the challenges of a prompt and accurate diagnosis of TA-TMA [transplant-associated thrombotic microangiopathy]. One of the challenges is to identify TA-TMA early in the course of the...

Addressing Diagnostic Challenges in HSCT-TMA and Exploring Emerging Biomarkers
https://www.onclive.com/view/addressing-diagnostic-challenges-in-hsct-tma-and-exploring-emerging-biomarkers

Oct 30th, 2020 - Biomarkers predictive of risk in hematopoietic stem cell transplantation (HSCT)–associated thrombotic microangiopathy (TMA) have undergone a recent evolution, with several new markers under exploration and many efforts focused on making current ma...

see more →